ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-692-5286, 6505016925286
CORONAVIRUS VACCINE

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 016925286
Codification Country
United States
Item Name Code
INC 80837
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-692-5286
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-692-5286


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-692-5286

National Stock Number (NSN) 6505-01-692-5286, or NIIN 016925286, (coronavirus vaccine) was assigned December 19, 2020 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.

There are 6 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 4 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 3 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

This NSN is assigned to Item Name Code (INC) 80837. [TO BE ADMINISTERED TO HUMANS TO PROVIDE ACQUIRED IMMUNITY AGAINST CORONA VIRUS DISEASE; TO INCLUDE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS TYPE 2 (SARS-COV-2 ), SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS (SARS-COV) AND MIDDLE EAST RESPIRATORY SYNDROME CORONA VIRUS (MERS-COV).]. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016925286 does not contain precious metals.

This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.

This information was last updated on .


Technical Characteristics

ADMINISTRATION
(CSGS) INJECTION
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) ADULT MODERNA COVID-19 VACCINE, VIAL 1S
PRIMARY CONTAINER CONTENT QUANTITY
(CRLK) 5.0 MILLILITERS
PRIMARY CONTAINER TYPE
(CQCT) VIAL, GLASS
SPECIAL FEATURES
(FEAT) SUSPENSION FOR INTRAMUSCULAR INJECTION; 1 MULTIPLE-DOSE VIAL OF 5 ML, EACH VIAL CONTAINS 10 TO 11 DOSES (0.5 ML EACH); EACH 0.5 ML DOSE OF THE MODERNA COVIID-19 VACCINE CONTAINS 100 MCG OF A NUCLEOSIDE-MODIFIED MESSENGER RNA ENCODING THE VIRAL SPIKE (S) GLYCOPROTEIN OF SARS-COV-2. EACH DOSE OF THE MODERNA COVID-19 VACCINE ALSO INCLUDES THE FOLLOWING INGREDIENTS: LIPIDS (SM-102; 1,2-DDIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL-2000 (PEG2000-DMG); CHOLESTEROL; AND 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE (DSPC), TROMETHAMINE, TROMETHAMINE HYDROCHLORIDE, ACETIC ACID, SODIUM ACETATE, AND SUCROSE. STORE FROZEN/BETWEEN -50 TO -15 DEGREES C (-58 TO 5 DEGREES F) UNTIL READY FOR USE; PROTECT FROM LIGHT; NO PRESERVATIVES; AFTER FIRST USE, HOLD AT 2 TO 25 DEGREES C (36 TO 77 DEGREES F), DISCARD AFTER 12 HOURS; DO NOT REFREEZE ONCE THAWED; FOR USE UNDER EMERGENCY USE AUTHORIZATION.
TOTAL PRIMARY CONTAINER QUANTITY
(CSCW) 1
VIRUS STRAIN
(CMDM) COVID-19
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) MODERNA COVID-19 VACCINE, VIAL

Manufacturer Part Numbers


Related Inventory

16F4423-3
6110-01-158-5866
AUDIO 2 PANEL D
Readily Available


 
Top